TNF‑α
IL‑1β
NF‑κB pathway
MAPK
STAT3
systemic low‑grade inflammation
T‑cell
T‑cell subsets
NK‑cell
IgG4
cytokine
serum cytokines
Th1/Th2/Th17 balance
Th1
Th2
Th17
TLR4
Myd88
regulatory vs. effector responses (in the context of immunity)
TSH
Serum TSH
T3
free T3
T4
free T4
cortisol
HPA axis
TRH
TSHβ
TBG
DIO1/2
glucocorticoid receptor
proteomic shift
metabolic rate
immune priming
paracrine signaling

eutopic endometrium
ectopic lesions (in endometriosis)
PGE₂
prostaglandin‑dependent recruitment of macrophages
VEGF‑mediated neo‑vasculogenesis
IL‑8
MCP‑1
JAK/STAT3 pathway
stromal cell
regulatory T cells
Foxp3⁺ Tregs
Th2/Th17 dominance
NF‑κB Entrapment
pro‑inflammatory loop
apoptotic pathway
estrogen‑mediated cytokine amplification
gram‑negative bacteria
lipopolysaccharide (LPS)
enterocyte
zonulin
tight‑junction disassembly
bile acid sequestration
D-glucuronobiosidase
farnesoid‑X‑receptor
Hepatic TSHβ suppression
catalase
gut mucosa
ROS
Kupffer cell
adrenal cortisol
adaptive immunity
CD4⁺ T cell apoptosis
macrophage
DIO1 type‑1 deiodinase
hepatocytes
oxidative stress
T4 → T3 conversion
cortisol‑mediated dampening of TRH release
IL‑1
IL‑1 receptor antagonist IL‑1Ra
pituitary TRH release
corticotropin‑releasing hormone (CRH)
hypothalamus
ACTH
inhibin‑β
pituitary
adrenal hyperplasia
IFN‑γ
TRH gene expression
TSH resistance
HPA axis response
NF‑κB cross‑talk
IL‑10
pituitary dephosphorylation of TSH receptor
chronic inflammation blunts GR sensitivity
anterior pituitary cortisol‑resistant state
lymphopenia
reduced NK cell cytotoxicity
increased IL‑10 release
susceptibility to autoimmunity
Hashimoto’s thyroiditis
Th2 dominance
epithelial cells
zonulin
increased gut permeability
HPA axis stimulation
immune suppression
inhibits DIO1
reduced metabolic clearance
TSH receptor desensitization
autoreactive T cells